Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
EV/Core EBITDA

    Back to All Ratios
BLISS GVS PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 8.916.725.865.464.84

What is the latest EV/Core EBITDA ratio of BLISS GVS PHARMA ?

The latest EV/Core EBITDA ratio of BLISS GVS PHARMA is 8.91 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar20268.91
Mar20256.72
Mar20245.86
Mar20235.46
Mar20224.84

How is EV/Core EBITDA of BLISS GVS PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 8.91
32.59
Mar2025 6.72
14.68
Mar2024 5.86
7.33
Mar2023 5.46
12.81
Mar2022 4.84 -

Other Financial Ratios of BLISS GVS PHARMA


Compare EV/Core EBITDA ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹7,679.6 Cr 3.7% 40.9% 356.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

3.7%

40.9%

356.5%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses